Thus, antioxidants seem to protect against toxic effect of doxorubicin only drug-sensitive tumor cells, and have no impact on cytotoxic action of doxorubicin toward tumor cells with impaired structure of Bax and p53 genes. Here, TP53 is linked to neoplasm.